Theyre metabolically healthy enough to tolerate gradual caloric reduction, they dont have severe kidney disease (since semaglutide is renally cleared), and they have the support or resources to maintain adequate protein intake and physical activity during treatment
As the half-life of retatrutide is 6 days, once weekly administration was sufficient with as expected gastrointestinal disturbance being the most common side effect and occurring in 63% of those on retatrutide, 60% on dulaglutide, and 54% of the placebo cohort [63]
angiogenic and anti-inflammatory complex
The TrimRx weight loss program illustrates the model: patients complete a detailed health assessment covering medical history, current conditions, and medications before any prescribing decision is considered, and a licensed provider then reviews that information to evaluate whether medication-supported weight management may be appropriate for that individual
Others dont get results, even after using the medication for months
Week-by-week semaglutide results show what typical progress looks like